Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review
Developing multiple soft tissue sarcomas (STSs) is a rare process, sparsely reported in the literature to date. Little is known about the pattern of disease development or outcomes in these patients. Patients were identified from three tertiary orthopaedic oncology centres in Canada and the UK. Pati...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2018/5392785 |
id |
doaj-b0125d17c430465bba34640a5a121853 |
---|---|
record_format |
Article |
spelling |
doaj-b0125d17c430465bba34640a5a1218532020-11-24T22:35:22ZengHindawi LimitedSarcoma1357-714X1369-16432018-01-01201810.1155/2018/53927855392785Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre ReviewJohnathan R. Lex0Ahmed Aoude1Jonathan D. Stevenson2Jay S. Wunder3Scott Evans4Peter C. Ferguson5Nikolaos A. Stavropoulos6Lee Jeys7Krista Goulding8Robert E. Turcotte9University of Birmingham, Birmingham B15 2TT, UKMcGill University Health Centre, Montreal, QC, H4A 3J1, CanadaRoyal Orthopaedic Hospital, Birmingham B31 2AP, UKUniversity of Toronto Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, ON, M5G 1X5, CanadaRoyal Orthopaedic Hospital, Birmingham B31 2AP, UKUniversity of Toronto Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, ON, M5G 1X5, CanadaMcGill University Health Centre, Montreal, QC, H4A 3J1, CanadaRoyal Orthopaedic Hospital, Birmingham B31 2AP, UKMcGill University Health Centre, Montreal, QC, H4A 3J1, CanadaMcGill University Health Centre, Montreal, QC, H4A 3J1, CanadaDeveloping multiple soft tissue sarcomas (STSs) is a rare process, sparsely reported in the literature to date. Little is known about the pattern of disease development or outcomes in these patients. Patients were identified from three tertiary orthopaedic oncology centres in Canada and the UK. Patients who developed multiple extremity STSs were collated retrospectively from prospective oncology databases. A literature review using MEDLINE was also performed. Six patients were identified in the case series from these three institutions, and five studies were identified from the literature review. Overall, 17 patients were identified with a median age of 51 years (range: 19 to 77). The prevalence of this manifestation in STS patients is 1 in 1225. The median disease-free interval between diagnoses was 2.3 years (range: 0 to 19 years). Most patients developed the secondary STS in a metachronous pattern, the remaining, synchronously. The median survival after the first sarcoma was 6 years, and it was 1.6 years after the second sarcoma. The 5-year overall survival rate was 83.3% and 50% following the first and second STS diagnoses, respectively. A diagnosis of two STSs does not confer a worse prognosis than the diagnosis of a single STS. Developing a second STS is a rare event with no identifiable histological pattern of occurrence. Presentation in a metachronous pattern is more common. A high degree of vigilance is required in patients with a previous STS both to detect both local recurrence and to identify new masses remote from the previous STS site. Acquiring an early histological diagnosis should be attempted.http://dx.doi.org/10.1155/2018/5392785 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Johnathan R. Lex Ahmed Aoude Jonathan D. Stevenson Jay S. Wunder Scott Evans Peter C. Ferguson Nikolaos A. Stavropoulos Lee Jeys Krista Goulding Robert E. Turcotte |
spellingShingle |
Johnathan R. Lex Ahmed Aoude Jonathan D. Stevenson Jay S. Wunder Scott Evans Peter C. Ferguson Nikolaos A. Stavropoulos Lee Jeys Krista Goulding Robert E. Turcotte Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review Sarcoma |
author_facet |
Johnathan R. Lex Ahmed Aoude Jonathan D. Stevenson Jay S. Wunder Scott Evans Peter C. Ferguson Nikolaos A. Stavropoulos Lee Jeys Krista Goulding Robert E. Turcotte |
author_sort |
Johnathan R. Lex |
title |
Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review |
title_short |
Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review |
title_full |
Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review |
title_fullStr |
Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review |
title_full_unstemmed |
Multiple Soft Tissue Sarcomas in a Single Patient: An International Multicentre Review |
title_sort |
multiple soft tissue sarcomas in a single patient: an international multicentre review |
publisher |
Hindawi Limited |
series |
Sarcoma |
issn |
1357-714X 1369-1643 |
publishDate |
2018-01-01 |
description |
Developing multiple soft tissue sarcomas (STSs) is a rare process, sparsely reported in the literature to date. Little is known about the pattern of disease development or outcomes in these patients. Patients were identified from three tertiary orthopaedic oncology centres in Canada and the UK. Patients who developed multiple extremity STSs were collated retrospectively from prospective oncology databases. A literature review using MEDLINE was also performed. Six patients were identified in the case series from these three institutions, and five studies were identified from the literature review. Overall, 17 patients were identified with a median age of 51 years (range: 19 to 77). The prevalence of this manifestation in STS patients is 1 in 1225. The median disease-free interval between diagnoses was 2.3 years (range: 0 to 19 years). Most patients developed the secondary STS in a metachronous pattern, the remaining, synchronously. The median survival after the first sarcoma was 6 years, and it was 1.6 years after the second sarcoma. The 5-year overall survival rate was 83.3% and 50% following the first and second STS diagnoses, respectively. A diagnosis of two STSs does not confer a worse prognosis than the diagnosis of a single STS. Developing a second STS is a rare event with no identifiable histological pattern of occurrence. Presentation in a metachronous pattern is more common. A high degree of vigilance is required in patients with a previous STS both to detect both local recurrence and to identify new masses remote from the previous STS site. Acquiring an early histological diagnosis should be attempted. |
url |
http://dx.doi.org/10.1155/2018/5392785 |
work_keys_str_mv |
AT johnathanrlex multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT ahmedaoude multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT jonathandstevenson multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT jayswunder multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT scottevans multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT petercferguson multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT nikolaosastavropoulos multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT leejeys multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT kristagoulding multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview AT roberteturcotte multiplesofttissuesarcomasinasinglepatientaninternationalmulticentrereview |
_version_ |
1725723741265068032 |